PI3K/Akt Pathway: A Role in δ-Opioid Receptor–Mediated RGC Neuroprotection-Reference-Cited by-同舟云学术

PI3K/Akt Pathway: A Role in δ-Opioid Receptor–Mediated RGC Neuroprotection

Published:2017-12-29 Issue:14 Volume:58 Page:6489
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Husain Shahid¹,Ahmad Anis²,Singh Sudha¹,Peterseim Carolyn¹,Abdul Yasir³,Nutaitis Matthew J.¹

Affiliation:

1. Hewitt Laboratory of the Ola B. Williams Glaucoma Center, Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, United States

2. Department of Radiation Oncology, University of Miami, Miami, Florida, United States

3. Department of Physiology, Augusta University, Augusta, Georgia, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Diagnostic Biomarkers for Glaucoma Based on Transcriptome Combined with Mendelian Randomization;2024-09-12

2. Novel insights into immunopathogenesis and crucial biomarkers between primary open‐angle glaucoma and systemic lupus erythematosus;iMetaOmics;2024-09-10

3. Circulating Small Extracellular Vesicles Involved in Systemic Regulation Respond to RGC Degeneration in Glaucoma;Advanced Science;2024-06-25

4. Targeting cGAS-STING signaling protects retinal ganglion cells from DNA damage-induced cell loss and promotes visual recovery in glaucoma;Aging;2024-06-06

5. Investigating the neuroprotective mechanism of Ganoderma lucidum in glaucoma treatment through network pharmacology and molecular docking analysis;2024-03-26